Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Hideaki Bando

Showing results (171-180 of 186) with videos related to

Pageof 19
Sort By:
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|November 8, 2024
A Tumor-Naïve ctDNA Assay Detects Minimal Residual Disease in Resected Stage II or III Colorectal Cancer and Predicts Recurrence: Subset Analysis from the GALAXY Study in CIRCULATE-JapanYoshiaki Nakamura, Kristiyana Kaneva, Christine Lo, et al.
European Journal of Cancer (Oxford, England : 1990)|October 7, 2025
Chronological survival improvement over time with oxaliplatin-based chemotherapy plus targeted agents in metastatic colorectal cancer: An ARCAD database studyKazumasa Yamamoto, Hideaki Bando, Toshihiro Misumi, et al.
BJC Reports|November 8, 2024
Different efficacy of tyrosine kinase inhibitors by KIT and PGFRA mutations identified in circulating tumor DNA for the treatment of refractory gastrointestinal stromal tumorsTadayoshi Hashimoto, Yoshiaki Nakamura, Yoshito Komatsu, et al.
JAMA Oncology|July 3, 2026
Circulating Tumor DNA Status and Adjuvant Chemotherapy in Resected Colorectal Liver MetastasesKozo Kataoka, Kazuma Ito, Yoshiaki Nakamura, et al.
Cancer Research Communications|May 9, 2025
Microbiome Landscape and Association with Response to Immune Checkpoint Inhibitors in Advanced Solid Tumors: A SCRUM-Japan MONSTAR-SCREEN StudyKentaro Sawada, Riu Yamashita, Shunsuke A Sakai, et al.
JCO Precision Oncology|February 21, 2022
Clinical Validity of Plasma-Based Genotyping for Microsatellite Instability Assessment in Advanced GI Cancers: SCRUM-Japan GOZILA SubstudyYoshiaki Nakamura, Wataru Okamoto, Tadamichi Denda, et al.
JAMA Oncology|November 30, 2023
A Learning Program for Treatment Recommendations by Molecular Tumor Boards and Artificial IntelligenceKuniko Sunami, Yoichi Naito, Yusuke Saigusa, et al.
Cancer Science|September 7, 2018
Clinical practice guidance for next-generation sequencing in cancer diagnosis and treatment (Edition 1.0)Kuniko Sunami, Hideaki Takahashi, Katsuya Tsuchihara, et al.
NPJ Precision Oncology|May 5, 2026
Survival outcomes with matched targeted therapy in advanced biliary tract cancer: a large global cohort analysisBinbin Zheng-Lin, Taro Shibuki, Heidi E Kosiorek, et al.
Nature Medicine|June 8, 2026
Post-adjuvant chemotherapy in ctDNA-positive patients with resected colorectal cancer: a randomized phase 3 trialHideaki Bando, Jun Watanabe, Yusuke Takahashi, et al.
Pageof 19

Showing results (171-180 of 186) with videos related to

Sort By:
Pageof 19
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|November 8, 2024
A Tumor-Naïve ctDNA Assay Detects Minimal Residual Disease in Resected Stage II or III Colorectal Cancer and Predicts Recurrence: Subset Analysis from the GALAXY Study in CIRCULATE-JapanYoshiaki Nakamura, Kristiyana Kaneva, Christine Lo, et al.
European Journal of Cancer (Oxford, England : 1990)|October 7, 2025
Chronological survival improvement over time with oxaliplatin-based chemotherapy plus targeted agents in metastatic colorectal cancer: An ARCAD database studyKazumasa Yamamoto, Hideaki Bando, Toshihiro Misumi, et al.
BJC Reports|November 8, 2024
Different efficacy of tyrosine kinase inhibitors by KIT and PGFRA mutations identified in circulating tumor DNA for the treatment of refractory gastrointestinal stromal tumorsTadayoshi Hashimoto, Yoshiaki Nakamura, Yoshito Komatsu, et al.
JAMA Oncology|July 3, 2026
Circulating Tumor DNA Status and Adjuvant Chemotherapy in Resected Colorectal Liver MetastasesKozo Kataoka, Kazuma Ito, Yoshiaki Nakamura, et al.
Cancer Research Communications|May 9, 2025
Microbiome Landscape and Association with Response to Immune Checkpoint Inhibitors in Advanced Solid Tumors: A SCRUM-Japan MONSTAR-SCREEN StudyKentaro Sawada, Riu Yamashita, Shunsuke A Sakai, et al.
JCO Precision Oncology|February 21, 2022
Clinical Validity of Plasma-Based Genotyping for Microsatellite Instability Assessment in Advanced GI Cancers: SCRUM-Japan GOZILA SubstudyYoshiaki Nakamura, Wataru Okamoto, Tadamichi Denda, et al.
JAMA Oncology|November 30, 2023
A Learning Program for Treatment Recommendations by Molecular Tumor Boards and Artificial IntelligenceKuniko Sunami, Yoichi Naito, Yusuke Saigusa, et al.
Cancer Science|September 7, 2018
Clinical practice guidance for next-generation sequencing in cancer diagnosis and treatment (Edition 1.0)Kuniko Sunami, Hideaki Takahashi, Katsuya Tsuchihara, et al.
NPJ Precision Oncology|May 5, 2026
Survival outcomes with matched targeted therapy in advanced biliary tract cancer: a large global cohort analysisBinbin Zheng-Lin, Taro Shibuki, Heidi E Kosiorek, et al.
Nature Medicine|June 8, 2026
Post-adjuvant chemotherapy in ctDNA-positive patients with resected colorectal cancer: a randomized phase 3 trialHideaki Bando, Jun Watanabe, Yusuke Takahashi, et al.
Pageof 19